Latest Pharma Insights
Futura Sets Sights On Taking Eroxon To China
With the grant of a patent, Futura is hoping to take its Eroxon product to China, a country with a large population of ED sufferers, the firm claims.
HBW Insight - December 19, 2025
With the grant of a patent, Futura is hoping to take its Eroxon product to China, a country with a large population of ED sufferers, the firm claims.
HBW Insight - December 19, 2025
Can US FDA Balance Inspection Generalists And ‘Simple Reform’ With Need For Expertise?
Former agency officials now representing industry worry that a deregulatory bent could be driving "Simple Reform" plan to merge all medical product and clinical research inspectorates and that specialist expertise gained in 2017 "Program Alignment" initiative will be reversed.
HBW Insight - December 19, 2025
Former agency officials now representing industry worry that a deregulatory bent could be driving "Simple Reform" plan to merge all medical product and clinical research inspectorates and that specialist expertise gained in 2017 "Program Alignment" initiative will be reversed.
HBW Insight - December 19, 2025
Lupin Joines Forces With PolyPeptide For Peptide APIs
Lupin has agreed a “long-term strategic alliance” with CDMO PolyPeptide that the firm says will bolster its supply chain for peptide APIs.
Generics Bulletin - December 19, 2025
Lupin has agreed a “long-term strategic alliance” with CDMO PolyPeptide that the firm says will bolster its supply chain for peptide APIs.
Generics Bulletin - December 19, 2025
UK Bodies Warn Market ‘Not Sustainable’ As Prices Hit ‘Rock Bottom’
The UK generics market risks becoming unsustainable as prices hit “rock bottom,” the House of Lords has been warned in a letter signed by multiple stakeholder associations including Medicines UK.
Generics Bulletin - December 19, 2025
The UK generics market risks becoming unsustainable as prices hit “rock bottom,” the House of Lords has been warned in a letter signed by multiple stakeholder associations including Medicines UK.
Generics Bulletin - December 19, 2025
Executives On The Move: Prolynx Gets A New CEO From Amgen
Recent moves in the industry include new CEO hires at Expression Therapeutics, DISCO Pharmaceuticals, Enliven Therapeutics and Certara, plus Carolyn Bertozzi returns to Eli Lilly Board.
Scrip - December 19, 2025
Recent moves in the industry include new CEO hires at Expression Therapeutics, DISCO Pharmaceuticals, Enliven Therapeutics and Certara, plus Carolyn Bertozzi returns to Eli Lilly Board.
Scrip - December 19, 2025
2025 Is A Year Of Firsts As Biosimilars Build Momentum In US
In a busy year for US biosimilars, more than a dozen approvals were seen as multiple brands faced competition for the first time – including Stelara. However, concerns persist over the “biosimilar void”, with hope that the latest FDA announcement on regulatory streamlining can help to fill the gap.
Generics Bulletin - December 19, 2025
In a busy year for US biosimilars, more than a dozen approvals were seen as multiple brands faced competition for the first time – including Stelara. However, concerns persist over the “biosimilar void”, with hope that the latest FDA announcement on regulatory streamlining can help to fill the gap.
Generics Bulletin - December 19, 2025
Alvotech And Teva Are Latest With US Eylea Settlement
Alvotech and Teva have become the latest Eylea biosimilar developers to announce a settlement allowing a US launch in late 2026. However, first they must clear the hurdle of FDA approval following a recent CRL.
Generics Bulletin - December 19, 2025
Alvotech and Teva have become the latest Eylea biosimilar developers to announce a settlement allowing a US launch in late 2026. However, first they must clear the hurdle of FDA approval following a recent CRL.
Generics Bulletin - December 19, 2025
Philips To Acquire SpectraWAVE To Expand Intravascular Imaging Portfolio
Philips says it intends to fold SpectraWAVE’s intravascular imaging and physiological assessment technologies into its existing intravascular ultrasound ecosystem, including Eagle Eye Platinum catheters and the IntraSight imaging and physiology workspace.
Medtech Insight - December 19, 2025
Philips says it intends to fold SpectraWAVE’s intravascular imaging and physiological assessment technologies into its existing intravascular ultrasound ecosystem, including Eagle Eye Platinum catheters and the IntraSight imaging and physiology workspace.
Medtech Insight - December 19, 2025
Pfizer-Cipla Seal India Marketing Deal: What It Entails
Cipla to distribute a diverse set of products from Pfizer in India, signaling, more widely, big pharma’s evolving playbook in the country.
Scrip - December 19, 2025
Cipla to distribute a diverse set of products from Pfizer in India, signaling, more widely, big pharma’s evolving playbook in the country.
Scrip - December 19, 2025
PD-(L)1 x VEGF Bispecific Plus ADC Combos Progress In Leaps And Bounds In 2025
Multiple novel combos of PD-(L)1 x VEGF-targeting bispecific antibodies and antibody-drug conjugates progressed through the clinic this year, many of which are from Chinese developers and with some advancing to first-line regimens.
Scrip - December 19, 2025
Multiple novel combos of PD-(L)1 x VEGF-targeting bispecific antibodies and antibody-drug conjugates progressed through the clinic this year, many of which are from Chinese developers and with some advancing to first-line regimens.
Scrip - December 19, 2025
Neuroethicists Advocate For More Guidelines For Neurotech
In this second of a three-part series, Medtech Insight spoke with three neuroethicists who raised concerns about privacy, patient safeguards and the need for comprehensive guidelines. These issues are becoming more pressing as BCI companies get ready to commercialize their products.
Medtech Insight - December 19, 2025
In this second of a three-part series, Medtech Insight spoke with three neuroethicists who raised concerns about privacy, patient safeguards and the need for comprehensive guidelines. These issues are becoming more pressing as BCI companies get ready to commercialize their products.
Medtech Insight - December 19, 2025
Executives On The Move: Prolynx Gets A New CEO From Amgen
Recent moves in the industry include new CEO hires at Expression Therapeutics, DISCO Pharmaceuticals, Enliven Therapeutics and Certara, plus Carolyn Bertozzi returns to Eli Lilly Board.
Scrip - December 19, 2025
Recent moves in the industry include new CEO hires at Expression Therapeutics, DISCO Pharmaceuticals, Enliven Therapeutics and Certara, plus Carolyn Bertozzi returns to Eli Lilly Board.
Scrip - December 19, 2025
Pfizer-Cipla Seal India Marketing Deal: What It Entails
Cipla to distribute a diverse set of products from Pfizer in India, signaling, more widely, big pharma’s evolving playbook in the country.
Scrip - December 19, 2025
Cipla to distribute a diverse set of products from Pfizer in India, signaling, more widely, big pharma’s evolving playbook in the country.
Scrip - December 19, 2025
PD-(L)1 x VEGF Bispecific Plus ADC Combos Progress In Leaps And Bounds In 2025
Multiple novel combos of PD-(L)1 x VEGF-targeting bispecific antibodies and antibody-drug conjugates progressed through the clinic this year, many of which are from Chinese developers and with some advancing to first-line regimens.
Scrip - December 19, 2025
Multiple novel combos of PD-(L)1 x VEGF-targeting bispecific antibodies and antibody-drug conjugates progressed through the clinic this year, many of which are from Chinese developers and with some advancing to first-line regimens.
Scrip - December 19, 2025
Philips To Acquire SpectraWAVE To Expand Intravascular Imaging Portfolio
Philips says it intends to fold SpectraWAVE’s intravascular imaging and physiological assessment technologies into its existing intravascular ultrasound ecosystem, including Eagle Eye Platinum catheters and the IntraSight imaging and physiology workspace.
Medtech Insight - December 19, 2025
Philips says it intends to fold SpectraWAVE’s intravascular imaging and physiological assessment technologies into its existing intravascular ultrasound ecosystem, including Eagle Eye Platinum catheters and the IntraSight imaging and physiology workspace.
Medtech Insight - December 19, 2025
Neuroethicists Advocate For More Guidelines For Neurotech
In this second of a three-part series, Medtech Insight spoke with three neuroethicists who raised concerns about privacy, patient safeguards and the need for comprehensive guidelines. These issues are becoming more pressing as BCI companies get ready to commercialize their products.
Medtech Insight - December 19, 2025
In this second of a three-part series, Medtech Insight spoke with three neuroethicists who raised concerns about privacy, patient safeguards and the need for comprehensive guidelines. These issues are becoming more pressing as BCI companies get ready to commercialize their products.
Medtech Insight - December 19, 2025
Futura Sets Sights On Taking Eroxon To China
With the grant of a patent, Futura is hoping to take its Eroxon product to China, a country with a large population of ED sufferers, the firm claims.
HBW Insight - December 19, 2025
With the grant of a patent, Futura is hoping to take its Eroxon product to China, a country with a large population of ED sufferers, the firm claims.
HBW Insight - December 19, 2025
Can US FDA Balance Inspection Generalists And ‘Simple Reform’ With Need For Expertise?
Former agency officials now representing industry worry that a deregulatory bent could be driving "Simple Reform" plan to merge all medical product and clinical research inspectorates and that specialist expertise gained in 2017 "Program Alignment" initiative will be reversed.
HBW Insight - December 19, 2025
Former agency officials now representing industry worry that a deregulatory bent could be driving "Simple Reform" plan to merge all medical product and clinical research inspectorates and that specialist expertise gained in 2017 "Program Alignment" initiative will be reversed.
HBW Insight - December 19, 2025
Lupin Joines Forces With PolyPeptide For Peptide APIs
Lupin has agreed a “long-term strategic alliance” with CDMO PolyPeptide that the firm says will bolster its supply chain for peptide APIs.
Generics Bulletin - December 19, 2025
Lupin has agreed a “long-term strategic alliance” with CDMO PolyPeptide that the firm says will bolster its supply chain for peptide APIs.
Generics Bulletin - December 19, 2025
UK Bodies Warn Market ‘Not Sustainable’ As Prices Hit ‘Rock Bottom’
The UK generics market risks becoming unsustainable as prices hit “rock bottom,” the House of Lords has been warned in a letter signed by multiple stakeholder associations including Medicines UK.
Generics Bulletin - December 19, 2025
The UK generics market risks becoming unsustainable as prices hit “rock bottom,” the House of Lords has been warned in a letter signed by multiple stakeholder associations including Medicines UK.
Generics Bulletin - December 19, 2025
2025 Is A Year Of Firsts As Biosimilars Build Momentum In US
In a busy year for US biosimilars, more than a dozen approvals were seen as multiple brands faced competition for the first time – including Stelara. However, concerns persist over the “biosimilar void”, with hope that the latest FDA announcement on regulatory streamlining can help to fill the gap.
Generics Bulletin - December 19, 2025
In a busy year for US biosimilars, more than a dozen approvals were seen as multiple brands faced competition for the first time – including Stelara. However, concerns persist over the “biosimilar void”, with hope that the latest FDA announcement on regulatory streamlining can help to fill the gap.
Generics Bulletin - December 19, 2025
Alvotech And Teva Are Latest With US Eylea Settlement
Alvotech and Teva have become the latest Eylea biosimilar developers to announce a settlement allowing a US launch in late 2026. However, first they must clear the hurdle of FDA approval following a recent CRL.
Generics Bulletin - December 19, 2025
Alvotech and Teva have become the latest Eylea biosimilar developers to announce a settlement allowing a US launch in late 2026. However, first they must clear the hurdle of FDA approval following a recent CRL.
Generics Bulletin - December 19, 2025
Deals Shaping The Industry, November 2025
An interactive look at pharma, medtech and diagnostics deals made during November 2025. Data courtesy of Biomedtracker.
In Vivo - December 18, 2025
An interactive look at pharma, medtech and diagnostics deals made during November 2025. Data courtesy of Biomedtracker.
In Vivo - December 18, 2025
Aphaia Pushes A Patient-First Vision For Obesity Care
The obesity field is entering the “sobering” phase of the hype cycle; GLP-1 drugs have opened the door but have limitations. Aphaia CSO Steffen-Sebastian Bolz talks to In Vivo about shifting the focus back to patient experience, not just maximal weight loss.
In Vivo - December 18, 2025
The obesity field is entering the “sobering” phase of the hype cycle; GLP-1 drugs have opened the door but have limitations. Aphaia CSO Steffen-Sebastian Bolz talks to In Vivo about shifting the focus back to patient experience, not just maximal weight loss.
In Vivo - December 18, 2025
Inductive Bio, Amgen Join ARPA-H’s Push To Replace Animal Tox With AI And Human Tissues
Inductive Bio receives $21m from ARPA-H to develop AI toxicity models using human tissues, partnering with Amgen to replace animal testing in drug development.
In Vivo - December 18, 2025
Inductive Bio receives $21m from ARPA-H to develop AI toxicity models using human tissues, partnering with Amgen to replace animal testing in drug development.
In Vivo - December 18, 2025
Health Systems Brace For CAR-T ‘Tsunami’
Industry warns healthcare infrastructure – not manufacturing – may be the real bottleneck as cell therapies eye mass-market diseases.
In Vivo - December 18, 2025
Industry warns healthcare infrastructure – not manufacturing – may be the real bottleneck as cell therapies eye mass-market diseases.
In Vivo - December 18, 2025